Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2020 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces Launch of CV™ Defense Daily Immune Support

SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products,...
September 02, 2020 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Launches New Website Reflecting Core Values and Mission of Improving Quality of Life Through Nature and Science

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp-derived cannabidiol (CBD) products, is...
August 20, 2020 08:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Participate in Alliance Global Partners Virtual Event

SAN DIEGO, Aug. 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp-derived cannabidiol (CBD) products, today...
August 13, 2020 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Experts Contribute to Journal of Dietary Supplements First Special Issue on Cannabinoids

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp-derived cannabidiol (CBD) products, is...
August 06, 2020 16:05 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Reports Second Quarter 2020 Financial Results

SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
August 05, 2020 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces Launch of Happy Lane™ CBD Product Line

SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today...
July 29, 2020 08:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line

SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today...
July 23, 2020 16:05 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Announce Second Quarter 2020 Results on August 6, 2020

SAN DIEGO, July 23, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
June 02, 2020 08:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD™ Products

SAN DIEGO, June 02, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
May 20, 2020 16:30 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020

SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right